Spectrum of myelodysplastic syndrome in patients evaluated for cytopenia(s). A Report from a Reference Centre in Saudi Arabia | Zendy

Nour AlMozain | Zendy; Ayman Mashi | Zendy; Qasem Alneami | Zendy; Amal Al-Omran | Zendy; Nasir Bakshi | Zendy; Tarek Owaidah | Zendy; Salem Khalil | Zendy; Haitham Khogeer | Zendy; Shahrukh K. Hashmi | Zendy; Suleimman AlSweedan | Zendy; Thomas Morris | Zendy; Randa Alnounou | Zendy

Open Access

Spectrum of myelodysplastic syndrome in patients evaluated for cytopenia(s). A Report from a Reference Centre in Saudi Arabia

Author(s) -

Nour AlMozain,

Ayman Mashi,

Qasem Alneami,

Amal Al-Omran,

Nasir Bakshi,

Tarek Owaidah,

Salem Khalil,

Haitham Khogeer,

Shahrukh K. Hashmi,

Suleimman AlSweedan,

Thomas Morris,

Randa Alnounou

Publication year - 2020

Publication title -

hematology/oncology and stem cell therapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.666

H-Index - 22

eISSN - 1658-3876

pISSN - 2589-0646

DOI - 10.1016/j.hemonc.2020.11.001

Subject(s) - cytopenia , myelodysplastic syndromes , medicine , dysplasia , trisomy 8 , bone marrow , international prognostic scoring system , hematology , pathology , oncology , cytogenetics , chromosome , biology , genetics , gene

Myelodysplastic syndrome (MDS) is a clonal disorder of hematopoietic stem cells, characterized by ineffective hematopoiesis, peripheral cytopenias along with hypercellularity of the bone marrow, and marked dysplastic features. Establishing MDS diagnosis is difficult due to nonspecific clinical presentation and imprecise morphological criteria. In anticipation to improve the diagnostic approach in this field, we aimed to characterize the clinical and morphological features of patients presented with cytopenias with a special focus on MDS.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research